© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 13, 1008-1009,
July 2, 2003
© 2003 Oxford University Press
CORRESPONDENCE |
Re: Discrete Alterations in the BZLF1 Promoter in Tumor and Non-Tumor-Associated EpsteinBarr Virus
Affiliation of authors: Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Correspondence to: Ka-Fai To, F.R.C.P.A., Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT Hong Kong (e-mail: kfto@cuhk.edu.hk).
| The first 10% of the full text of this article appears below. |
In their recent article, Gutiérrez et al. (1) identified three EpsteinBarr virus (EBV) variants in the BZLF1 promoter Zp (Zp-P [considered the prototypical sequence], Zp-V3, and Zp-V4) and postulated that these might result in different lytic potentials and be differentially expressed among individuals with nonmalignant and malignant diseases. Hong Kong and Southern China are considered to be endemic